Showing results (1041-1050 of 3,030) with videos related to
Sort By:
Pageof 303
Current Pharmaceutical Biotechnology|December 23, 2011
Reducing the development of antibiotic resistance in critical care unitsMarjolein P D Deege, David L PatersonCurrent Pharmaceutical Biotechnology|December 23, 2011
A novel lily-of-the-valley fragrance contrast agent for magnetic resonance and fluorescence imaging of prostate cancer cellsAlexander Sturzu, Hartmut Echner, Uwe Klose, et al.Current Pharmaceutical Biotechnology|January 31, 2012
Metabotropic glutamate receptors as targets for novel antipsychotic treatmentsL J Gray, A J Hannan, X ZhangCurrent Pharmaceutical Biotechnology|January 31, 2012
Immunological treatment options for schizophreniaNorbert Müller, Aye-Mu Myint, Markus J SchwarzCurrent Pharmaceutical Biotechnology|January 31, 2012
Innovative treatment approaches in schizophrenia enhancing neuroplasticity: aerobic exercise, erythropoetin and repetitive transcranial magnetic stimulationT Wobrock, A Hasan, P FalkaiCurrent Pharmaceutical Biotechnology|January 28, 2012
The role of an experimental model of atherosclerosis: apoE-knockout mice in developing new drugs against atherogenesisJacek JawienCurrent Pharmaceutical Biotechnology|January 28, 2012
Regeneration of vessel wall functionality and vascular restoration therapy with biodegradable stents -- current statusRafal Depukat, Lukasz Rzeszutko, Dariusz DudekCurrent Pharmaceutical Biotechnology|January 28, 2012
Novel therapeutic approaches in limiting oxidative stress and inflammationAgnieszka Spychalowicz, Grzegorz Wilk, Tomasz Śliwa, et al.Current Pharmaceutical Biotechnology|January 28, 2012
Left ventricular hypertrophy in isolated aortic stenosis: primetime for the ventricleCristina Gavina, Inês Falcão-Pires, Francisco Rocha-Gonçalves, et al.Current Pharmaceutical Biotechnology|January 28, 2012
Cellular mechanisms for diastolic dysfunction in the human heartDániel Czuriga, Walter J Paulus, István Czuriga, et al.Pageof 303